✦ LIBER ✦

98 Treating Metastatic Melanoma With the BRAF Inhibitor Vemurafenib and Mechanisms of Resistance

✍ Scribed by P. Chapman

Book ID: 117662639
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 53 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70802-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vemurafenib (PLX4032): An Orally Availab

Vemurafenib (PLX4032): An Orally Available Inhibitor of Mutated BRAF for the Treatment of Metastatic Melanoma

✍ Heakal, Y.; Kester, M.; Savage, S. 📂 Article 📅 2011 🏛 Harvey Whitney Books Company 🌐 English ⚖ 164 KB

Outcomes of patients with metastatic mel

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

✍ Ackerman, Allison; Klein, Oliver; McDermott, David F.; Wang, Wei; Ibrahim, Nagea 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

1403 POSTER DISCUSSION Molecular Testing

1403 POSTER DISCUSSION Molecular Testing for BRAF V600 Mutations in Clinical Trials of the BRAF Inhibitor Vemurafenib (RG7204/PLX4032) in Metastatic Melanoma – a Comparison With Sánger Sequencing

✍ S. Anderson; K. Bloom; R. Schilling; J.R.J. Lee; R. Langland; H. Halait; H.J. La 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

The nature and management of metastatic

The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition

✍ Chan, Matthew M. K.; Haydu, Lauren E.; Menzies, Alexander M.; Azer, Mary W. F.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

Phase II Trial (BREAK-2) of the BRAF Inh

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma

✍ Ascierto, P. A.; Minor, D.; Ribas, A.; Lebbe, C.; O'Hagan, A.; Arya, N.; Guckert 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 182 KB

Cutaneous manifestations of dabrafenib (

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

✍ Anforth, R.M.; Blumetti, T.C.M.P.; Kefford, R.F.; Sharma, R.; Scolyer, R.A.; Kos 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB